Sergi Mas
Biographic Data
| ID | 7654784 |
|---|---|
| NAME | Sergi Mas |
| GIVEN NAMES | Sergi |
| FAMILY NAME | Mas |
| SIGNATURE | MAS S |
| AFFILIATIONS | Centro de Investigación Biomédica en Red de Salud Mental |
| ORCID | 0000-0003-3336-6298 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Applied pharmacogenetics to predict response to treatment of first psychotic episode
The application of personalized medicine in patients with first-episode psychosis (FEP) requires tools for classifying patients according to their response to treatment, considering both treatment efficacy and toxicity. However, several limitations have hindered its translation into clinical practice. Here, we describe the rationale, aims and methodology of Applied Pharmacogenetics to Predict Response to Treatment of First Psychotic Episode (the …
The effect of age on DNA concentration from whole saliva
OBJECTIVES: Adequate quantity and quality of the DNA isolated from saliva samples are crucial for ensuring successful genotyping rates in genetic studies. However, there is little information about these issues when saliva samples are collected from children. The objectives of this study were to assess whether there are differences in DNA quality or quantity isolated from saliva samples of children at different ages and adolescents compared to ad…
No prominent works on this page.
The effect of age on DNA concentration from whole saliva
OBJECTIVES: Adequate quantity and quality of the DNA isolated from saliva samples are crucial for ensuring successful genotyping rates in genetic studies. However, there is little information about these issues when saliva samples are collected from children. The objectives of this study were to assess whether there are differences in DNA quality or quantity isolated from saliva samples of children at different ages and adolescents compared to ad…
Applied pharmacogenetics to predict response to treatment of first psychotic episode
The application of personalized medicine in patients with first-episode psychosis (FEP) requires tools for classifying patients according to their response to treatment, considering both treatment efficacy and toxicity. However, several limitations have hindered its translation into clinical practice. Here, we describe the rationale, aims and methodology of Applied Pharmacogenetics to Predict Response to Treatment of First Psychotic Episode (the …
Biology (2 works) · Genetics (2 works) · Genotype (2 works) · Alternative medicine (1 work) · Biochemistry (1 work) · Bioinformatics (1 work) · Bipolar Disorder and Treatment (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · DNA (1 work)